UPDATE: HCA Holdings Sees 2011 Adjusted EBITDA at the Upper End or Slightly Above the Previous Guidance

On January 10, 2012, management of HCA Holdings, Inc.

will deliver a presentation at the 30th Annual J. P. Morgan Healthcare Conference at 9:00 am. During the presentation, the Company will state that based on its preliminary review of fourth quarter results it expects to be at the upper end or slightly above its previously issued guidance, as most recently stated in the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on November 8, 2011, of growth in Adjusted EBITDA of zero to two percent for the full year 2011, assuming the Company meets revised HITECH income estimates and related reimbursement parameters and excluding any financial impact of the recently completed acquisition of its partner's interest in the HealthOne venture. Richard M. Bracken, the Company's Chief Executive Officer, will make the following statement: “Based on our preliminary review of fourth quarter results, we now expect to report full year 2011 Adjusted EBITDA at the upper end or slightly above the guidance which we provided during our November 8th investor call. Our guidance of 0-2% Adjusted EBITDA growth for the full year 2011 included HITECH revenues and related expenses, but excluded accretion from our October 14th acquisition of the minority interest in the HealthOne partnership. During the fourth quarter of 2011, we continued to see solid volume growth over prior year; however, we also experienced revenue rate growth pressure primarily due to Medicaid reimbursement reductions and lower acuity levels. Our expense management improvement reported in the third quarter of this year, continued to be highly effective in the fourth quarter as well. Since we are in the process of closing our books for December, we will not be providing any further comments on the fourth quarter until our earnings release and investor call which is scheduled for February 2nd. We also will not comment today on our expectations for 2012 results. We will provide 2012 guidance in our fourth quarter earnings release and investor call.”